• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哈萨克斯坦胃癌死亡率趋势。

Trend in Gastric Cancer Mortality in Kazakhstan.

机构信息

Astana Medical University, Astana, Kazakhstan.

Central Asian Institute for Medical Research, Astana, Kazakhstan.

出版信息

Asian Pac J Cancer Prev. 2022 Nov 1;23(11):3779-3789. doi: 10.31557/APJCP.2022.23.11.3779.

DOI:10.31557/APJCP.2022.23.11.3779
PMID:36444591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9930978/
Abstract

OBJECTIVE

The aim is to study the trends in gastric cancer (GC) mortality in Kazakhstan.

METHODS

Data on those who died from GC and on the annual population were obtained from the Bureau of National Statistics of the Agency for Strategic Planning and Reforms of the Republic of Kazakhstan. A retrospective study was carried out for the period 2009-2018 using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific mortality rates are determined according to the generally accepted methodology used in sanitary statistics.

RESULTS

GC mortality in Kazakhstan is considered to be decreasing. It was determined that during the studied period 19,672 died of this cancer. The mean of death was 67.8 with 95% CI of 67.6 to 68.0. The highest mortality rates per 100,000 in the entire population were found in the age groups 75-79 years (145.9±24.1), 80-84 years (161.0±11.0), and 85+ years (116.5±16.4). Trends in age-related mortality rates had a pronounced tendency to increase in 70-74 years (T=+4.3%, R2=0.1924) and to decrease in the age of up to 30 (T=-8.7%, R2=0.2426). The average annual standardized mortality rate was 13.2 per 100,000, and in trends   tended to decrease (T=-5.8%; R2=0.9763). In all regions, there is a decrease in mortality, except for the city of Astana. During categorization mortality rates were determined on the basis of standardized indicators: low - up to 12.9, average - from 12.9 to 15.1, high - above 15.1 per 100,000 for the entire population.

CONCLUSION

The mortality rates from GC tend to decrease, while the downward trends and the degree of their approximation are expressed in almost all regions. The study of regional mortality has theoretical and practical significance for monitoring and evaluating the effectiveness of early detection and treatment. Health authorities should take into account the results obtained when organizing antitumor measures.

摘要

目的

研究哈萨克斯坦胃癌(GC)死亡率的趋势。

方法

从哈萨克斯坦战略规划和改革署国家统计局获得 GC 死亡人数和年度人口数据。使用肿瘤流行病学的描述性和分析方法对 2009-2018 年期间进行了回顾性研究。根据卫生统计中使用的公认方法,确定广泛的、粗的和特定年龄的死亡率。

结果

哈萨克斯坦的 GC 死亡率被认为呈下降趋势。研究期间共 19672 人死于这种癌症。平均死亡率为 67.8,95%CI 为 67.6 至 68.0。整个人群中每 10 万人死亡率最高的年龄组为 75-79 岁(145.9±24.1)、80-84 岁(161.0±11.0)和 85 岁以上(116.5±16.4)。与年龄相关的死亡率趋势在 70-74 岁时呈现出明显的上升趋势(T=+4.3%,R2=0.1924),而在 30 岁以下时则呈下降趋势(T=-8.7%,R2=0.2426)。平均年标准化死亡率为每 10 万人 13.2,呈下降趋势(T=-5.8%,R2=0.9763)。除阿斯塔纳市外,所有地区的死亡率均下降。在分类中,死亡率是根据标准化指标确定的:低-低至 12.9、中-12.9 至 15.1、高-高至 15.1 以上每 10 万人。

结论

GC 的死亡率呈下降趋势,而下降趋势及其接近程度在几乎所有地区都有所体现。对区域死亡率的研究对于监测和评估早期发现和治疗的效果具有理论和实际意义。卫生当局在组织抗肿瘤措施时应考虑到所获得的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/4a71f07a2f4e/APJCP-23-3779-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/4a6cb12d3fee/APJCP-23-3779-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/1bf968ae4c30/APJCP-23-3779-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/ecb475bae0bc/APJCP-23-3779-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/be12b607be8d/APJCP-23-3779-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/a1578bb0565a/APJCP-23-3779-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/72f63807ae06/APJCP-23-3779-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/4a71f07a2f4e/APJCP-23-3779-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/4a6cb12d3fee/APJCP-23-3779-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/1bf968ae4c30/APJCP-23-3779-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/ecb475bae0bc/APJCP-23-3779-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/be12b607be8d/APJCP-23-3779-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/a1578bb0565a/APJCP-23-3779-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/72f63807ae06/APJCP-23-3779-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/9930978/4a71f07a2f4e/APJCP-23-3779-g007.jpg

相似文献

1
Trend in Gastric Cancer Mortality in Kazakhstan.哈萨克斯坦胃癌死亡率趋势。
Asian Pac J Cancer Prev. 2022 Nov 1;23(11):3779-3789. doi: 10.31557/APJCP.2022.23.11.3779.
2
Colorectal Cancer Mortality in Kazakhstan: Spatio-Temporal Epidemiological Assessment.哈萨克斯坦结直肠癌死亡率:时空流行病学评估。
Asian Pac J Cancer Prev. 2022 Mar 1;23(3):953-960. doi: 10.31557/APJCP.2022.23.3.953.
3
Epidemiology of Breast Cancer Mortality in Kazakhstan, trends and Geographic Distribution.哈萨克斯坦乳腺癌死亡率的流行病学,趋势和地理分布。
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3361-3371. doi: 10.31557/APJCP.2023.24.10.3361.
4
Epidemiology of Lung Cancer in Kazakhstan: Trends and Geographic Distribution.哈萨克斯坦肺癌的流行病学:趋势和地理分布。
Asian Pac J Cancer Prev. 2023 May 1;24(5):1521-1532. doi: 10.31557/APJCP.2023.24.5.1521.
5
Lymphosarcoma Incidence in Kazakhstan: A Retrospective Survey (2010-2019).哈萨克斯坦淋巴肉瘤发病率:回顾性调查(2010-2019 年)。
Asian Pac J Cancer Prev. 2023 Jun 1;24(6):1885-1896. doi: 10.31557/APJCP.2023.24.6.1885.
6
Liver Cancer Incidence in Kazakhstan: Fifteen-Year Retrospective Study.哈萨克斯坦的肝癌发病率:十五年回顾性研究。
Asian Pac J Cancer Prev. 2024 May 1;25(5):1763-1775. doi: 10.31557/APJCP.2024.25.5.1763.
7
New Trends of Cervical Cancer Incidence in Kazakhstan.哈萨克斯坦宫颈癌发病率的新趋势。
Asian Pac J Cancer Prev. 2021 Apr 1;22(4):1295-1304. doi: 10.31557/APJCP.2021.22.4.1295.
8
Geographic Variability of Gastric Cancer Incidence in Kazakhstan.哈萨克斯坦胃癌发病率的地域差异。
Asian Pac J Cancer Prev. 2022 Jun 1;23(6):1935-1944. doi: 10.31557/APJCP.2022.23.6.1935.
9
Corpus Uteri Cancer in Kazakhstan: Recent Incidence Trends.哈萨克斯坦子宫体癌:近期发病趋势。
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):849-857. doi: 10.31557/APJCP.2023.24.3.849.
10
Trends in Stage-Specific Kidney Cancer Incidence in Kazakhstan, 2005-2019.哈萨克斯坦 2005-2019 年特定分期肾癌发病率趋势。
Asian Pac J Cancer Prev. 2024 Sep 1;25(9):3239-3249. doi: 10.31557/APJCP.2024.25.9.3239.

引用本文的文献

1
A Study of the Effectiveness of Apoptosis Biomarkers in the Diagnosis of Gastric Cancer in Kazakhstan: A Review of Systematic Evidence.哈萨克斯坦胃癌诊断中凋亡生物标志物有效性的研究:系统证据综述
Med J Islam Repub Iran. 2025 Apr 23;39:59. doi: 10.47176/mjiri.39.59. eCollection 2025.
2
Prevalence and risk factors of infection among outpatient in Karaganda city (Kazakhstan).卡拉干达市(哈萨克斯坦)门诊患者感染的患病率及危险因素
Future Sci OA. 2025 Dec;11(1):2461429. doi: 10.1080/20565623.2025.2461429. Epub 2025 Feb 10.
3
Review of Methods for Detection in Kazakhstan.

本文引用的文献

1
Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures.高卫生支出发达国家胃癌病死率与发病率比值的改善。
Front Public Health. 2021 Aug 17;9:713895. doi: 10.3389/fpubh.2021.713895. eCollection 2021.
2
Global Incidence and Mortality of Gastric Cancer, 1980-2018.全球 1980-2018 年胃癌发病率和死亡率。
JAMA Netw Open. 2021 Jul 1;4(7):e2118457. doi: 10.1001/jamanetworkopen.2021.18457.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
哈萨克斯坦检测方法综述。
JGH Open. 2025 Jan 17;9(1):e70101. doi: 10.1002/jgh3.70101. eCollection 2025 Jan.
4
Burden of major cancer types in Almaty, Kazakhstan.哈萨克斯坦阿拉木图主要癌症类型的负担。
Sci Rep. 2024 Sep 4;14(1):20536. doi: 10.1038/s41598-024-71449-5.
5
Trends in Avoidable Mortality in Kazakhstan From 2015 to 2021.2015 年至 2021 年哈萨克斯坦可避免死亡率趋势。
Int J Health Policy Manag. 2024;13:7919. doi: 10.34172/ijhpm.2024.7919. Epub 2024 Mar 13.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Chemoprevention of gastric cancer development after eradication therapy in an East Asian population: Meta-analysis.东亚人群根除治疗后胃癌发展的化学预防:荟萃分析。
World J Gastroenterol. 2020 Apr 21;26(15):1820-1840. doi: 10.3748/wjg.v26.i15.1820.
5
[Analysis of the long-term trend of mortality and years of life lost of gastric cancer in Tianjin from 1999 to 2015].1999年至2015年天津市胃癌死亡率及寿命损失年数的长期趋势分析
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Feb 6;54(2):160-164. doi: 10.3760/cma.j.issn.0253-9624.2020.02.009.
6
Burden of Gastric Cancer.胃癌负担。
Clin Gastroenterol Hepatol. 2020 Mar;18(3):534-542. doi: 10.1016/j.cgh.2019.07.045. Epub 2019 Jul 27.
7
Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review.近期进展:胃癌的外科治疗进展:综述。
Med Sci Monit. 2019 May 13;25:3537-3541. doi: 10.12659/MSM.916475.
8
Epidemiology of gastric cancer: global trends, risk factors and prevention.胃癌流行病学:全球趋势、风险因素与预防
Prz Gastroenterol. 2019;14(1):26-38. doi: 10.5114/pg.2018.80001. Epub 2018 Nov 28.
9
Unequal burden of mortality from gastric cancer in Brazil and its regions, 2000-2015.巴西及其地区 2000-2015 年胃癌死亡率的不平等负担。
Gastric Cancer. 2019 Jul;22(4):675-683. doi: 10.1007/s10120-018-00916-6. Epub 2019 Jan 2.
10
Biomarkers of gastric cancer: Current topics and future perspective.胃癌的生物标志物:当前的研究热点和未来展望。
World J Gastroenterol. 2018 Jul 14;24(26):2818-2832. doi: 10.3748/wjg.v24.i26.2818.